157 related articles for article (PubMed ID: 15150566)
1. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer.
Polinder S; Homs MY; Siersema PD; Steyerberg EW;
Br J Cancer; 2004 Jun; 90(11):2067-72. PubMed ID: 15150566
[TBL] [Abstract][Full Text] [Related]
2. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
[TBL] [Abstract][Full Text] [Related]
3. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
[TBL] [Abstract][Full Text] [Related]
4. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
Wenger U; Johnsson E; Bergquist H; Nyman J; Ejnell H; Lagergren J; Ruth M; Lundell L
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1369-77. PubMed ID: 16292092
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
6. Self-expanding metal stents in malignant esophageal obstruction: a comparison between two stent types.
Schmassmann A; Meyenberger C; Knuchel J; Binek J; Lammer F; Kleiner B; Hürlimann S; Inauen W; Hammer B; Scheurer U; Halter F
Am J Gastroenterol; 1997 Mar; 92(3):400-6. PubMed ID: 9068458
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.
Tian D; Wen H; Fu M
World J Surg Oncol; 2016 Jan; 14(1):18. PubMed ID: 26800661
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer.
Knyrim K; Wagner HJ; Bethge N; Keymling M; Vakil N
N Engl J Med; 1993 Oct; 329(18):1302-7. PubMed ID: 7692297
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic palliation of unresectable malignant oesophageal strictures with self-expanding metal stents: comparing Ultraflex and Esophacoil stents.
Riccioni ME; Shah SK; Tringali A; Ciletti S; Mutignani M; Perri V; Zuccalà G; Coppola R; Costamagna G
Dig Liver Dis; 2002 May; 34(5):356-63. PubMed ID: 12118954
[TBL] [Abstract][Full Text] [Related]
10. Palliative treatment of oesophageal carcinoma--efficacy of plastic versus self-expandable stents.
Sanyika C; Corr P; Haffejee A
S Afr Med J; 1999 Jun; 89(6):640-3. PubMed ID: 10443214
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy.
Nicholson DA; Haycox A; Kay CL; Rate A; Attwood S; Bancewicz J
Clin Radiol; 1999 Apr; 54(4):212-5. PubMed ID: 10210338
[TBL] [Abstract][Full Text] [Related]
12. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
[TBL] [Abstract][Full Text] [Related]
13. [Self-expanding metal stents for palliation of malignant oesophageal obstruction].
Tolmácsi B; Rábai K; Szamosi T; Czeglédi Z; Gyökeres T; Zsigmond F; Banai J
Magy Seb; 2009 Apr; 62(2):59-66. PubMed ID: 19386565
[TBL] [Abstract][Full Text] [Related]
14. WITHDRAWN: Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2011 Feb; (2):CD005048. PubMed ID: 21328271
[TBL] [Abstract][Full Text] [Related]
15. Interventions for dysphagia in oesophageal cancer.
Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
[TBL] [Abstract][Full Text] [Related]
16. Cost comparison study of two different follow-up protocols after surgery for oesophageal cancer.
Polinder S; Verschuur EM; Siersema PD; Kuipers EJ; Steyerberg EW
Eur J Cancer; 2009 Aug; 45(12):2110-5. PubMed ID: 19398325
[TBL] [Abstract][Full Text] [Related]
17. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
[TBL] [Abstract][Full Text] [Related]
18. Management of inoperable malignant oesophageal strictures with fully covered WallFlex(®) stent: a multicentre prospective study.
Repici A; Jovani M; Hassan C; Solito B; Di Mitri R; Buffoli F; Macrì G; Fregonese D; Cennamo V; De Bellis M; Anderloni A; Siersema PD
Dig Liver Dis; 2014 Dec; 46(12):1093-8. PubMed ID: 25262010
[TBL] [Abstract][Full Text] [Related]
19. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.
Bergquist H; Wenger U; Johnsson E; Nyman J; Ejnell H; Hammerlid E; Lundell L; Ruth M
Dis Esophagus; 2005; 18(3):131-9. PubMed ID: 16045572
[TBL] [Abstract][Full Text] [Related]
20. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection.
Steyerberg EW; Homs MY; Stokvis A; Essink-Bot ML; Siersema PD;
Gastrointest Endosc; 2005 Sep; 62(3):333-40. PubMed ID: 16111947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
